On the use of DNA methylation inhibitors and the reversal of transcriptional silencing.
El-Osta
Assam
A
D001374:Azacitidine / Q000031:analogs & derivatives* / Q000494:pharmacology; D019175:DNA Methylation / Q000187:drug effects*; D015257:DNA-Cytosine Methylases / Q000037:antagonists & inhibitors; D000077209:Decitabine; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000494:pharmacology; D020868:Gene Silencing / Q000187:drug effects*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000209:etiology; D014158:Transcription, Genetic / Q000187:drug effects
D004791:Enzyme Inhibitors; D000077209:Decitabine; C068513:DNA modification methylase AcyI; D015257:DNA-Cytosine Methylases; D001374:Azacitidine